Clinical trials group ICON has reported a 38% increase in its full year net revenues, to $631m.
ICON, a development service provider to pharmaceutical, biotechnology and medical device industries, announced its results for the fourth quarter ended 31 December 2007 today, as well as its full fiscal year 2007.
Net profits for the year were $15.8m, compared with $11.4m last year.
For the full year, ICON's cash flow was $49.2m and capital expenditure was $75.4m.
The company said it has seen record net bookings of $344m in its fourth quarter, leading to bookings of over $1 billion for the full year.
ICON, headquartered in Leopardstown, Dublin, conducts clinical trials and development projects locally and globally.
